- FDA Letter to Health Care Providers Related to Potential Risks, Including Death, with Liquid-Filled Intragastric Balloons for Weight Loss NOT Related to The Obalon Gas-Filled Balloon (6/8/2018)
- Obalon Balloon System to be Included in Two Presentations at the Aesthetic Meeting 2017 (5/1/2017)
- David Moatazedi Joins Obalon Therapeutics, Inc. Board of Directors (3/15/2017)
- Obalon Therapeutics, Inc. :OBLN-US: Earnings Analysis: 2016 By the Numbers : March 10, 2017 (3/10/2017)
- Obalon Therapeutics Inc Announces Fourth Quarter and Year End 2016 Financial Results Conference Call (2/15/2017)
- Obalon Therapeutics, Inc. to Ring The Nasdaq Stock Market Closing Bell (1/19/2017)
- Obalon Therapeutics Inc. (Nasdaq: OBLN) to Ring The Nasdaq Stock Market Closing Bell (1/18/2017)
- Jonah Shacknai Joins Obalon Therapeutics, Inc. Board of Directors (1/17/2017)
- Obalon Announces Initial Commercial Patient Placements of the First and Only Swallowable, FDA-Approved Balloon System for Weight Loss (1/13/2017)
- Obalon Therapeutics To Present at Two Upcoming Investor Conferences (11/14/2016)